Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Congenital Abnormalities × Thalidomide × Clear all

Sponsor

Conditions

Multiple Myeloma 33 Neoplasms, Plasma Cell 10 Prostatic Neoplasms 3 Immunoglobulin Light-chain Amyloidosis 3 Central Nervous System Neoplasms 3 Waldenstrom Macroglobulinemia 2 Sarcoma 2 Recurrence 2 Rectal Neoplasms 2 Neuroblastoma 2 Neoplasms 2 Lymphoma, Mantle-Cell 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Glioma 2 Glioblastoma 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Amyloidosis 2 Adenocarcinoma of Lung 2 Renal Insufficiency, Chronic 1 Renal Insufficiency 1 Polyneuropathies 1 Paraproteinemias 1 Neurotoxicity Syndromes 1 Motor Activity 1 Melanoma 1

Interventions

fludarabine phosphate 32 Cytarabine 29 Cyclophosphamide 24 Whole-Body Irradiation 23 Peripheral Blood Stem Cell Transplantation 23 Mycophenolic Acid 22 Busulfan 21 Tacrolimus 19 Cyclosporine 15 Filgrastim 14 Etoposide 14 Antilymphocyte Serum 14 Methotrexate 13 Melphalan 11 Idarubicin 9 Granulocyte Colony-Stimulating Factor 9 Clofarabine 8 Mitoxantrone 7 Flow Cytometry 7 Sirolimus 6 Radiotherapy 6 Cord Blood Stem Cell Transplantation 6 aldesleukin 5 Vorinostat 5 Daunorubicin 5 thymoglobulin 4 fludarabine 4 alvocidib 4 Thiotepa 4 Polymerase Chain Reaction 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡